Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

Rethinking and rigor brings promising protein for cancer therapy

Rethinking and rigor brings promising protein for cancer therapy

Scientists create a tool to identify individuals at risk of developing different myeloid leukaemias

Scientists create a tool to identify individuals at risk of developing different myeloid leukaemias

Scientists find evidence of unintended impacts from anti-cancer drugs

Scientists find evidence of unintended impacts from anti-cancer drugs

Adding immunity to human kidney-on-a-chip advances cancer drug testing

Adding immunity to human kidney-on-a-chip advances cancer drug testing

New resource to help families understand paediatric Hodgkin lymphoma

New resource to help families understand paediatric Hodgkin lymphoma

Journal review summarises latest research on gamma delta T cells for tumour immunotherapy

Journal review summarises latest research on gamma delta T cells for tumour immunotherapy

Cuproptosis-related MTF1 inhibits kidney renal clear cell carcinoma progression by suppressing proliferation and regulating immune cell infiltration

Cuproptosis-related MTF1 inhibits kidney renal clear cell carcinoma progression by suppressing proliferation and...

SQUID increases accessibility to single-cell tumour profiling to improve treatment outcomes

SQUID increases accessibility to single-cell tumour profiling to improve treatment outcomes

Additional COVID-19 boosters can benefit cancer patients—how often they should get them depends on their treatment

Additional COVID-19 boosters can benefit cancer patients—how often they should get them depends on their treatment

European Commission approves reduced dosing frequency of teclistamab for multiple myeloma

European Commission approves reduced dosing frequency of teclistamab for multiple myeloma

More from ecancer